Skip to main content

Table 2 Possible contraindications to UAE

From: Implementation of uterine artery embolization for symptomatic fibroids in the Netherlands: an inventory and preference study

Contraindication (Median, IQR) UAE+ (n = 43) (median, IQR) UAE- (n = 43) (median, IQR) P-value
Subserosal pedunculated fibroid (type 7) 7.00 (5–9) 7.00 (5–9) 0.07
Submucous fibroid (type 2) 2.00 (0–5) 1.00 (0–3) 0.68
Only bulky complaints 3.00 (1–7) 3.00 (1–7) 0.71
Suspected concurrent adenomyosis 4.00 (1–7) 5.00 (2–7) 0.15
Uterus size > 20 weeks of gestation 4.00 (2–6) 5.00 (3–8) 0.49
A wish to conceive 9.00 (8–10) 8.00 (8–10) 0.16
  1. Median on a scale of 0–10; 0 = no, it is no contraindication for UAE 10 = yes, I it is a contraindication for UAE
  2. IQR Interquartile range P-value calculated with Mann-Whitney U test